Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 2, 2013, Pages 215-223

  Lenglet, Sébastien ^a   Thomas, Aurélien ^b   Soehnlein, Oliver ^c,d   Montecucco, Fabrizio ^a,e   Burger, Fabienne ^a   Pelli, Graziano ^a   Galan, Katia ^a   Cravatt, Benjamin ^f   Staub, Christian ^b   Steffens, Sabine ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF GENOA   (Italy)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

endocannabinoids; lipid signaling; N acyl ethanolamines; neutrophils; plaque stability; regulatory T cells

Indexed keywords

ANANDAMIDE; APOLIPOPROTEIN E; CD4 ANTIGEN; CHOLESTEROL; CXCL1 CHEMOKINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; FATTY ACID AMIDASE; GAMMA INTERFERON; GELATINASE B; N OLEOYLETHANOLAMINE; PALMIDROL; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BONE MARROW; CELL MIGRATION; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; SMOOTH MUSCLE FIBER; SPLEEN; T LYMPHOCYTE;

AMIDOHYDROLASES; ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ARACHIDONIC ACIDS; ATHEROSCLEROSIS; BENZAMIDES; CARBAMATES; CELLS, CULTURED; CHEMOKINE CXCL1; CHOLESTEROL; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ENZYME INHIBITORS; ETHANOLAMINES; GENOTYPE; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NEUTROPHIL INFILTRATION; NEUTROPHILS; OLEIC ACIDS; PALMITIC ACIDS; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; POLYUNSATURATED ALKAMIDES; SPLEEN; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872900862     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300275     Document Type: Article

References (41)

1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
2. Libby P. Infammation in atherosclerosis. Nature. 2002;420:868-874.
3. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204-212.
4. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508-519.
5. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new defnitions and risk assessment strategies: Part I. Circulation. 2003;108:1664-1672.
6. Newby AC. Metalloproteinase expression in monocytes and mac-rophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol. 2008;28:2108-2114.
7. Newby AC, George SJ, Ismail Y, Johnson JL, Sala-Newby GB, Thomas AC. Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thromb Haemost. 2009;101:1006-1011.
8. Newby AC. Do metalloproteinases destabilize vulnerable atherosclerotic plaques? Curr Opin Lipidol. 2006;17:556-561.
9. van Leeuwen M, Gijbels MJ, Duijvestijn A, Smook M, van de Gaar MJ, Heeringa P, de Winther MP, Tervaert JW. Accumulation of myeloper-oxidase- positive neutrophils in atherosclerotic lesions in LDLR-/-mice. Arterioscler Thromb Vasc Biol. 2008;28:84-89.
10. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, Krohn R, Schober A, Sperandio M, Soehnlein O, Bornemann J, Tacke F, Biessen EA, Weber C. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008;102:209-217.
11. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122:1837-1845.
12. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Neutrophil infltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894-2900.
13. Leclercq A, Houard X, Philippe M, Ollivier V, Sebbag U, Meilhac O, Michel JB. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol. 2007;82:1420-1429.
14. Ionita MG, van den Borne P, Catanzariti LM, Moll FL, de Vries JP, Pasterkamp G, Vink A, de Kleijn DP. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol. 2010;30:1842-1848.
15. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res. 2012;110:875-888.
16. Montecucco F, Matias I, Lenglet S, Petrosino S, Burger F, Pelli G, Braunersreuther V, Mach F, Steffens S, Di Marzo V. Regulation and possible role of endocannabinoids and related mediators in hypercholester-olemic mice with atherosclerosis. Atherosclerosis. 2009;205:433-441.
17. Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, Miyata K, Nakayama M, Kaikita K, Obata T, Takeya M, Ogawa H. Activated endocannabinoid system in coronary artery disease and antiinfam-matory effects of cannabinoid 1 receptor blockade on macrophages. Circulation. 2009;119:28-36.
18. Pacher P, Steffens S. The emerging role of the endocannabinoid system in cardiovascular disease. Semin Immunopathol. 2009;31:63-77.
19. Quercioli A, Pataky Z, Vincenti G, et al. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. Eur Heart J. 2011;32:1369-1378.
20. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA. 2001;98:9371-9376.
21. Long JZ, LaCava M, Jin X, Cravatt BF. An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. J Lipid Res. 2011;52:337-344.
22. Thomas A, Hopfgartner G, Giroud C, Staub C. Quantitative and qualitative profling of endocannabinoids in human plasma using a triple quad-rupole linear ion trap mass spectrometer with liquid chromatography. Rapid Commun Mass Spectrom. 2009;23:629-638.
23. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med. 2006;203:1273-1282.
24. Guzmán M, Lo Verme J, Fu J, Oveisi F, Blázquez C, Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem. 2004;279:27849-27854.
25. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-infammatory actions of palmitoylethanolamide. Mol Pharmacol. 2005;67:15-19.
26. LoVerme J, La Rana G, Russo R, Calignano A, Piomelli D. The search for the palmitoylethanolamide receptor. Life Sci. 2005;77:1685-1698.
27. Montecucco F, Di Marzo V. At the heart of the matter: the endocan-nabinoid system in cardiovascular function and dysfunction. Trends Pharmacol Sci. 2012;33:331-340.
28. Montecucco F, Di Marzo V, da Silva RF, et al. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur Heart J. 2012;33: 846-856.
29. Dol-Gleizes F, Paumelle R, Visentin V, Marés AM, Desitter P, Hennuyer N, Gilde A, Staels B, Schaeffer P, Bono F. Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-defcient mice. Arterioscler Thromb Vasc Biol. 2009;29:12-18.
30. Lichtman AH, Shelton CC, Advani T, Cravatt BF. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain. 2004;109:319-327.
31. Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M, Lutz B. The endogenous canna-binoid system protects against colonic infammation. J Clin Invest. 2004;113:1202-1209.
32. Mukhopadhyay P, Horváth B, Rajesh M, Matsumoto S, Saito K, Bátkai S, Patel V, Tanchian G, Gao RY, Cravatt BF, Haskó G, Pacher P. Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury. Free Radic Biol Med. 2011;50:179-195.
33. Simon GM, Cravatt BF. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo. Mol Biosyst. 2010;6:1411-1418.
34. Pacher P. Cannabinoid CB1 receptor antagonists for atherosclerosis and cardiometabolic disorders: new hopes, old concerns? Arterioscler Thromb Vasc Biol. 2009;29:7-9.
35. Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. CB1 can-nabinoid receptor antagonism: a new strategy for the treatment of liver fbrosis. Nat Med. 2006;12:671-676.
36. Rajesh M, Bátkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horváth B, Holovac E, Cinar R, Liaudet L, Mackie K, Haskó G, Pacher P. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, infammation, and fbrosis in diabetic cardiomyopathy. Diabetes. 2012;61:716-727.
37. Sluijter JP, Pulskens WP, Schoneveld AH, Velema E, Strijder CF, Moll F, de Vries JP, Verheijen J, Hanemaaijer R, de Kleijn DP, Pasterkamp G. Matrix metalloproteinase 2 is associated with stable and matrix metal-loproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke. 2006;37:235-239.
38. Montecucco F, Lenglet S, Gayet-Ageron A, Bertolotto M, Pelli G, Palombo D, Pane B, Spinella G, Steffens S, Raffaghello L, Pistoia V, Ottonello L, Pende A, Dallegri F, Mach F. Systemic and intraplaque mediators of infammation are increased in patients symptomatic for ischemic stroke. Stroke. 2010;41:1394-1404.
39. Rotzius P, Thams S, Soehnlein O, Kenne E, Tseng CN, Björkström NK, Malmberg KJ, Lindbom L, Eriksson EE. Distinct infltra-tion of neutrophils in lesion shoulders in ApoE-/-mice. Am J Pathol. 2010;177:493-500.
40. Döring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S, Gallo RL, Weber C, Soehnlein O. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res. 2012;110:1052-1056.
41. Griffn GK, Newton G, Tarrio ML, Bu DX, Maganto-Garcia E, Azcutia V, Alcaide P, Grabie N, Luscinskas FW, Croce KJ, Lichtman AH. IL-17 and TNF-α sustain neutrophil recruitment during infamma-tion through synergistic effects on endothelial activation. J Immunol. 2012;188:6287-6299.